Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
Clinical trial NCT00005959 · UNKNOWN
Trial details
- NCT number
- NCT00005959
- Sponsor
- Amgen
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-12-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.